Asset Details
Do you wish to reserve the book?
Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study
Do you wish to request the book?
Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study
2023
Overview
BackgroundThe Rezum system is one of the latest minimally invasive surgical treatments for benign prostatic hyperplasia.MethodsWe retrospectively reviewed all patients who underwent the Rezum treatment in seven different Italian institutions. A successful urinary outcome was defined as: ≥50% improvement in the IPSS <7, improvement in peak flow ≥50% and/or more than 15 ml/s, ≥1-point improvement in the QoL questionnaire and in the absence of perioperative major complications (AUR, transfusion) or postoperative incontinence. A successful sexual outcome was defined as postoperative (latest follow up consultation) antegrade ejaculation or no variation in ejaculatory function and an increase, or stability or max 1 class reduction, in IIEF-5.Results262 patients were enrolled with a follow-up period of 11 months (IQR 5–15). No early or late serious adverse events (Clavien III–IV) occurred. Early complications occurred in 39.3% of cases, with 4 cases of clot retention and one case of blood transfusion. Urge incontinence was reported by 6 patients (2.2%). A treatment failure requiring re-intervention occurred in 4 cases (1.5%). The preoperative antegrade ejaculation rate was 56.5%, and after the procedure it increased to 78.2%. The increase of ≥1-point in the QoL was achieved in 92.7% of the cases. Optimal urinary and sexual outcomes were achieved in 52.9% and 87.8%, respectively.ConclusionsIn our series, water vapor intraprostatic injections seem to be an effective and safe procedure.
Publisher
Nature Publishing Group
